Uncovering the Role of N-Acetyl-Aspartyl-Glutamate as a Glutamate Reservoir in Cancer

Tu Nguyen, Brian James Kirsch, Ryoichi Asaka, Karim Nabi, Addison Quinones, Jessica Tan, Marjorie Justine Antonio, Felipe Camelo, Ting Li, Stephanie Nguyen, Giang Hoang, Kiet Nguyen, Sunag Udupa, Christos Sazeides, Yao An Shen, Amira Elgogary, Juvenal Reyes, Liang Zhao, Andre Kleensang, Kaisorn Lee ChaichanaThomas Hartung, Michael J. Betenbaugh, Suely K. Marie, Jin G. Jung, Tian-Li Wang, Edward Gabrielson, Quy Hoa Le Thi

Research output: Contribution to journalArticle

Abstract

Nguyen et al. show that NAAG is more abundant in higher grade cancers and a source of glutamate in cancers expressing GCPII, the enzyme that hydrolyzes NAAG to glutamate and NAA. The results suggest that GCPII is a viable target for cancer therapy, either alone or in combination with glutaminase inhibition.

Original languageEnglish (US)
Pages (from-to)491-501.e6
JournalCell Reports
Volume27
Issue number2
DOIs
StatePublished - Apr 9 2019

Fingerprint

Glutamic Acid
Glutaminase
Neoplasms
Enzymes
N-acetyl-1-aspartylglutamic acid
Therapeutics

Keywords

  • GCPII
  • glutamate carboxypeptidase II
  • glutamate deprivation
  • glutamate reservoir
  • glutaminase inhibitor
  • metabolomics
  • N-acetyl-aspartyl-glutamate
  • NAAG
  • stable isotope resolved

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Uncovering the Role of N-Acetyl-Aspartyl-Glutamate as a Glutamate Reservoir in Cancer. / Nguyen, Tu; Kirsch, Brian James; Asaka, Ryoichi; Nabi, Karim; Quinones, Addison; Tan, Jessica; Antonio, Marjorie Justine; Camelo, Felipe; Li, Ting; Nguyen, Stephanie; Hoang, Giang; Nguyen, Kiet; Udupa, Sunag; Sazeides, Christos; Shen, Yao An; Elgogary, Amira; Reyes, Juvenal; Zhao, Liang; Kleensang, Andre; Chaichana, Kaisorn Lee; Hartung, Thomas; Betenbaugh, Michael J.; Marie, Suely K.; Jung, Jin G.; Wang, Tian-Li; Gabrielson, Edward; Le Thi, Quy Hoa.

In: Cell Reports, Vol. 27, No. 2, 09.04.2019, p. 491-501.e6.

Research output: Contribution to journalArticle

Nguyen, T, Kirsch, BJ, Asaka, R, Nabi, K, Quinones, A, Tan, J, Antonio, MJ, Camelo, F, Li, T, Nguyen, S, Hoang, G, Nguyen, K, Udupa, S, Sazeides, C, Shen, YA, Elgogary, A, Reyes, J, Zhao, L, Kleensang, A, Chaichana, KL, Hartung, T, Betenbaugh, MJ, Marie, SK, Jung, JG, Wang, T-L, Gabrielson, E & Le Thi, QH 2019, 'Uncovering the Role of N-Acetyl-Aspartyl-Glutamate as a Glutamate Reservoir in Cancer', Cell Reports, vol. 27, no. 2, pp. 491-501.e6. https://doi.org/10.1016/j.celrep.2019.03.036
Nguyen T, Kirsch BJ, Asaka R, Nabi K, Quinones A, Tan J et al. Uncovering the Role of N-Acetyl-Aspartyl-Glutamate as a Glutamate Reservoir in Cancer. Cell Reports. 2019 Apr 9;27(2):491-501.e6. https://doi.org/10.1016/j.celrep.2019.03.036
Nguyen, Tu ; Kirsch, Brian James ; Asaka, Ryoichi ; Nabi, Karim ; Quinones, Addison ; Tan, Jessica ; Antonio, Marjorie Justine ; Camelo, Felipe ; Li, Ting ; Nguyen, Stephanie ; Hoang, Giang ; Nguyen, Kiet ; Udupa, Sunag ; Sazeides, Christos ; Shen, Yao An ; Elgogary, Amira ; Reyes, Juvenal ; Zhao, Liang ; Kleensang, Andre ; Chaichana, Kaisorn Lee ; Hartung, Thomas ; Betenbaugh, Michael J. ; Marie, Suely K. ; Jung, Jin G. ; Wang, Tian-Li ; Gabrielson, Edward ; Le Thi, Quy Hoa. / Uncovering the Role of N-Acetyl-Aspartyl-Glutamate as a Glutamate Reservoir in Cancer. In: Cell Reports. 2019 ; Vol. 27, No. 2. pp. 491-501.e6.
@article{1f4fb09611004f089c08a1908e9e2ad4,
title = "Uncovering the Role of N-Acetyl-Aspartyl-Glutamate as a Glutamate Reservoir in Cancer",
abstract = "Nguyen et al. show that NAAG is more abundant in higher grade cancers and a source of glutamate in cancers expressing GCPII, the enzyme that hydrolyzes NAAG to glutamate and NAA. The results suggest that GCPII is a viable target for cancer therapy, either alone or in combination with glutaminase inhibition.",
keywords = "GCPII, glutamate carboxypeptidase II, glutamate deprivation, glutamate reservoir, glutaminase inhibitor, metabolomics, N-acetyl-aspartyl-glutamate, NAAG, stable isotope resolved",
author = "Tu Nguyen and Kirsch, {Brian James} and Ryoichi Asaka and Karim Nabi and Addison Quinones and Jessica Tan and Antonio, {Marjorie Justine} and Felipe Camelo and Ting Li and Stephanie Nguyen and Giang Hoang and Kiet Nguyen and Sunag Udupa and Christos Sazeides and Shen, {Yao An} and Amira Elgogary and Juvenal Reyes and Liang Zhao and Andre Kleensang and Chaichana, {Kaisorn Lee} and Thomas Hartung and Betenbaugh, {Michael J.} and Marie, {Suely K.} and Jung, {Jin G.} and Tian-Li Wang and Edward Gabrielson and {Le Thi}, {Quy Hoa}",
year = "2019",
month = "4",
day = "9",
doi = "10.1016/j.celrep.2019.03.036",
language = "English (US)",
volume = "27",
pages = "491--501.e6",
journal = "Cell Reports",
issn = "2211-1247",
publisher = "Cell Press",
number = "2",

}

TY - JOUR

T1 - Uncovering the Role of N-Acetyl-Aspartyl-Glutamate as a Glutamate Reservoir in Cancer

AU - Nguyen, Tu

AU - Kirsch, Brian James

AU - Asaka, Ryoichi

AU - Nabi, Karim

AU - Quinones, Addison

AU - Tan, Jessica

AU - Antonio, Marjorie Justine

AU - Camelo, Felipe

AU - Li, Ting

AU - Nguyen, Stephanie

AU - Hoang, Giang

AU - Nguyen, Kiet

AU - Udupa, Sunag

AU - Sazeides, Christos

AU - Shen, Yao An

AU - Elgogary, Amira

AU - Reyes, Juvenal

AU - Zhao, Liang

AU - Kleensang, Andre

AU - Chaichana, Kaisorn Lee

AU - Hartung, Thomas

AU - Betenbaugh, Michael J.

AU - Marie, Suely K.

AU - Jung, Jin G.

AU - Wang, Tian-Li

AU - Gabrielson, Edward

AU - Le Thi, Quy Hoa

PY - 2019/4/9

Y1 - 2019/4/9

N2 - Nguyen et al. show that NAAG is more abundant in higher grade cancers and a source of glutamate in cancers expressing GCPII, the enzyme that hydrolyzes NAAG to glutamate and NAA. The results suggest that GCPII is a viable target for cancer therapy, either alone or in combination with glutaminase inhibition.

AB - Nguyen et al. show that NAAG is more abundant in higher grade cancers and a source of glutamate in cancers expressing GCPII, the enzyme that hydrolyzes NAAG to glutamate and NAA. The results suggest that GCPII is a viable target for cancer therapy, either alone or in combination with glutaminase inhibition.

KW - GCPII

KW - glutamate carboxypeptidase II

KW - glutamate deprivation

KW - glutamate reservoir

KW - glutaminase inhibitor

KW - metabolomics

KW - N-acetyl-aspartyl-glutamate

KW - NAAG

KW - stable isotope resolved

UR - http://www.scopus.com/inward/record.url?scp=85063761659&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063761659&partnerID=8YFLogxK

U2 - 10.1016/j.celrep.2019.03.036

DO - 10.1016/j.celrep.2019.03.036

M3 - Article

C2 - 30970252

AN - SCOPUS:85063761659

VL - 27

SP - 491-501.e6

JO - Cell Reports

JF - Cell Reports

SN - 2211-1247

IS - 2

ER -